Literature DB >> 34724098

α-Klotho released from HK-2 cells inhibits osteogenic differentiation of renal interstitial fibroblasts by inactivating the Wnt-β-catenin pathway.

Zewu Zhu1, Shuhao Ruan1, Yingcheng Jiang1, Fang Huang1, Weiping Xia1, Jinbo Chen1, Yu Cui1, Cheng He1, Feng Zeng1, Yang Li1, Zhiyong Chen2, Hequn Chen3.   

Abstract

Randall's plaques (RP) are well established as precursor lesions of idiopathic calcium oxalate (CaOx) stones, and the process of biomineralization driven by osteogenic-like cells has been highlighted in RP formation, but the mechanism is poorly understood. Given the inhibitory role of α-Klotho (KL), an aging suppressor protein with high expression in kidneys, in ectopic calcification and the close association between KL gene polymorphisms and urolithiasis susceptibility, we determined the potential role of KL in RP formation. This study found that both soluble KL (s-KL) and transmembrane KL (m-KL) were downregulated, and that s-KL but not m-KL was inversely correlated with upregulation of osteogenic markers in RP tissues. Additionally, s-KL expression was markedly suppressed in human renal interstitial fibroblasts (hRIFs) and slightly suppressed in HK-2 cells after osteogenic induction, intriguingly, which was echoed to the greater osteogenic capability of hRIFs than HK-2 cells. Further investigations showed the inhibitory effect of s-KL on hRIF osteogenic differentiation in vitro and in vivo. Moreover, coculture with recombinant human KL (r-KL) or HK-2 cells suppressed osteogenic differentiation of hRIFs, and this effect was abolished by coculture with KL-silenced HK-2 cells or the β-catenin agonist SKL2001. Mechanistically, s-KL inactivated the Wnt-β-catenin pathway by directly binding to Wnt2 and upregulating SFRP1. Further investigations identified activation of the Wnt-β-catenin pathway and downregulation of SFRP1 and DKK1 in RP tissues. In summary, this study identified s-KL deficiency as a pathological feature of RP and revealed that s-KL released from HK-2 cells inhibited osteogenic differentiation of hRIFs by inactivating the Wnt-β-catenin pathway, not only providing in-depth insight into the role of s-KL in renal interstitial biomineralization but also shedding new light on the interaction of renal tubular epithelial cells with interstitial cells to clarify RP formation.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  HK-2; Osteogenic differentiation; Randall's plaques; Renal interstitial fibroblasts; α-Klotho; β-catenin

Mesh:

Substances:

Year:  2021        PMID: 34724098     DOI: 10.1007/s00018-021-03972-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  36 in total

1.  The kidney is the principal organ mediating klotho effects.

Authors:  Karolina Lindberg; Risul Amin; Orson W Moe; Ming-Chang Hu; Reinhold G Erben; Annika Östman Wernerson; Beate Lanske; Hannes Olauson; Tobias E Larsson
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

Review 2.  Stones in 2012: epidemiology, prevention and redefining therapeutic standards.

Authors:  Andreas Neisius; Glenn M Preminger
Journal:  Nat Rev Urol       Date:  2013-01-08       Impact factor: 14.432

3.  Trends in urological stone disease: a 5-year update of hospital episode statistics.

Authors:  Hendrik Heers; Benjamin W Turney
Journal:  BJU Int       Date:  2016-05-26       Impact factor: 5.588

4.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

5.  Unified theory on the pathogenesis of Randall's plaques and plugs.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urolithiasis       Date:  2014-08-14       Impact factor: 3.436

6.  Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice.

Authors:  Shun-Ai Li; Masami Watanabe; Hiroshi Yamada; Atsushi Nagai; Masahiro Kinuta; Kohji Takei
Journal:  Cell Struct Funct       Date:  2004-12       Impact factor: 2.212

7.  Renal Papillary Mapping and Quantification of Randall's Plaque in Pediatric Calcium Oxalate Stone Formers.

Authors:  Anne Darves-Bornoz; Tracy Marien; John Thomas; Gabriel Fiscus; John Brock; Douglass Clayton; Nicole L Miller
Journal:  J Endourol       Date:  2019-10       Impact factor: 2.942

Review 8.  Mechanisms of human kidney stone formation.

Authors:  Andrew P Evan; Elaine M Worcester; Fredric L Coe; James Williams; James E Lingeman
Journal:  Urolithiasis       Date:  2014-08-10       Impact factor: 3.436

9.  Nanoscale Analysis of Randall's Plaques by Electron Energy Loss Spectromicroscopy: Insight in Early Biomineral Formation in Human Kidney.

Authors:  Clément Gay; Emmanuel Letavernier; Marie-Christine Verpont; Michael Walls; Dominique Bazin; Michel Daudon; Nadine Nassif; Odile Stéphan; Marta de Frutos
Journal:  ACS Nano       Date:  2020-01-27       Impact factor: 15.881

10.  Human proximal tubular cells can form calcium phosphate deposits in osteogenic culture: role of cell death and osteoblast-like transdifferentiation.

Authors:  Giovanna Priante; Monica Ceol; Lisa Gianesello; Claudio Furlan; Dorella Del Prete; Franca Anglani
Journal:  Cell Death Discov       Date:  2019-01-28
View more
  1 in total

1.  Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway.

Authors:  Yan-Ni Wang; Hong-Jiao Liu; Li-Li Ren; Ping Suo; Liang Zou; Ya-Mei Zhang; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.